GV-58
GV-58 is a novel N- and P/Q-type calcium (Ca2+) channel agonist with EC50s of 7.21 and 8.81 μM, respectively. GV-58 slows the deactivation of channels, resulting in a large increase in presynaptic Ca2+ entry during activity. GV-58 can be used in lambert-eaton myasthenic syndrome (LEMS) research[1][2][3].
Product Specifications
CAS Number
1402821-41-3
UNSPSC
12352005
Hazard Statement
H315, H319
Target
Calcium Channel
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/GV-58.html
Purity
99.22
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CC[C@@H](NC1=NC(NCC2=CC=C(C)S2)=C3N=CN(CCC)C3=N1)CO
Molecular Formula
C18H26N6OS
Molecular Weight
374.50
Precautions
H315, H319
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
N-type calcium channel; P/Q-type calcium channel
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Macrophage Colony-stimulating Factor 1, Recombinant, Human, aa33-255, His-Tag (CSF1, M-CSF, MCSF, Lanimostim)
Puf60 sgRNA CRISPR Lentivector (Mouse) (Target 2)
Anti-EIF4EL3 (EIF4E2) Mouse Monoclonal Antibody [Clone ID: OTI1F2]